WWW.UK.X-PDF.RU

˲ - , ,

 
<< HOME
CONTACTS




( )
.: (050)697-98-00, (067)176-69-25, (063)846-28-10
׸

( )
.: (050)697-98-00, (067)176-69-25, (063)846-28-10
׸
 >>  . C 01.02.00
Pages:     | 1 | 2 || 4 |

616.342-002:616.132.2-005.4 ί ϲ в ů ˲ϲ ² ̲ Ͳ ...

-- [ 3 ] --

6. Redeen S. Chronic gastritis. Diagnosis, natural history and consequences. Lincoping, Sweden. 2003. 71 p.

7. . . / . . , . . // . 2011. 1. . 49-56.

8. Ridker P. M. Novel Risk Factors for Systemic Atherosclerosis A Comparison of C-Reactive protein, Fibrinogen, Homocysteine, Lipoprotein(a), and Standard Cholesterol Screening as Predictors of Peripheral Arterial Disease / P. M. Ridker, M. J. Stampfer, N. Rifai // JAMA. 2001. Vol. 285, No 19. P. 2841 2845.

9. . . : / . . // . 2004. 1. . 22-34.

10. . . : , , / . . . --: , 2007. 255 .

11. . . . / . . , . . // . 2007. 2(52). . 242255.

12. . . : . . .

. : 14.00.06 / . . . , 2008. 20 .

13. Abraham J. M. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? / J. M. Abraham, L. Cho // Cleve Clin. J. Med. 2010. Vol. 77 (12). P. 911918.

14. Jacobsen D. W. Total plasma homocysteine: the mediator/marker controversy continues. 1994 / D. W. Jacobsen, V.J. Gatautis, R. Green et al. // Clin. Chem. 2009. Vol. 55(9). P. 1742-1743.

15. Kristensen B. Hyperhomocysteinemia and Hypofibrinolysis in Young Adults With Ischemic Stroke / B. Kristensen, J. Malm, T. K. Nilsson et al. // Stroke. 1999. Vol. 30. P. 974980.

16. Boushey C. J. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease.

Probable benefits of increasing folic acid intakes / C. J. Boushey, S. A. Beresford, G. S. Omenn et al. // JAMA. 1995. Vol.274 (13). P. 10491057.

17. Eikelboom J. W. Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and SmallArtery Disease but Not Other Etiologic Subtypes of Ischemic Stroke / J. W. Eikelboom, G. J. Hankey, S. S. Anand et al. // Stroke. 2000. Vol. 31. P. 10691075.

18. Xiao Y. Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects/ Y. Xiao, Y. Zhang, X. Ly et al. // Lipids Health Dis. 2011.

Vol. 10(137). P. 17.

19. Rolita L. Homocysteine and mobility in older adults / L. Rolita, R. Holtzer, C. Wang et al. // J. Am. Geriatr.

Soc. 2010. Vol. 58(3). P. 545550.

20. Yetley E. A. Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use / E. A. Yetley, C. L. Johnson // Am. J. Clin. Nutr. 2011. Vol. 94(1). P. 32233.

21. Fowler B. Foreword to special issue on homocysteine disorders / B. Fowler, H. J. Blom, V. Koich // J. Inherit. Metab. Dis. 2011. Vol. 34(1). P. 12.

22. Manolescu B. N. Homocysteine and vitamin therapy in stroke prevention and treatment: a review / B. N. Manolescu, E. Oprea, I.C. Farcasanu et al. // Acta Biochim. Pol. 2010. Vol. 57(4). P. 467477.

23. Yetley E. A. Overview of a roundtable on NHANES monitoring of biomarkers of folate and vitamin B-12 status: measurement procedure issues / E. A. Yetley, P. M. Coates, C. L. Johnson // Am. J. Clin. Nutr. - 2011.

Vol. 94(1). P. 297302.

24. Bova I. The A677V Methylenetetrahydrofolate Reductase Gene Polymorphism and Carotid Atherosclerosis / I. Bova, J. Chapman, C. Sylantiev et al. // Stroke. 1999. Vol.30. P. 21802182.

25. Brustolin S. Genetics of homocysteine metabolism and associated disorders / S. Brustolin, R. Giugliani, T. M. Flix // Braz. J. Med. Biol. Res. 2010. Vol. 43(1). P. 17

26. Campanile A. Multiple Coronary Artery Thrombosis in 5,10-Methylenetetrahydrofolate Reductase Gene Mutation/ A. Campanile, F.B. Sozzi, G.B. Danzi // Cardiology Research and Practice. 2011. Vol.2011. P. 13

27. Carmel R. Update on Cobalamin, Folate, and Homocysteine / R. Carmel, R. Green, D. S. Rosenblatt et al. // Hematology. 2003. P. 6281

28. He K. Folate, Vitamin B6, and B12 Intakes in Relation to Risk of Stroke Among Men / K. He, Merchant A., Rimm E.B. et al. // Stroke. 2004. Vol. 35. P. 169174.

29. Weng L.-C. Is Ischemic Stroke Risk Related to Folate Status or Other Nutrients Correlated With Folate Intake? / L.-C. Weng, W.-T. Yeh, C.-H. Bai et al. // Stroke. 2008. Vol. 39. P. 31523158.

30. Das M. A community based study of the relationship between homocysteine and some of the life style factors / M. Das, M. Ghose, N. C. Borah // Indian J. Clin. Biochem. 2010. Vol. 25(3). P. 295301.

31. Obeid R. Homocysteine and cholesterol: guilt by association? / R. Obeid, W. Herrmann // Stroke. 2009. Vol. 40(7). P. 1.

32. Gorelick P. B. Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy. An Invited Review / P. B. Gorelick // Stroke. 2002. Vol. 33. P. 862875.

33. Miller J. W. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate / J. W. Miller, M. G. Garrod, L. H. Allen et al. // Am. J. Clin. Nutr. 2009. Vol. 90(6). P. 15861592.

34. . . , Helicobacter pylori , / . . // . 2007. 4(36). . 2932.

35. Kamat G. T. A Cross-Sectional Study to Detect the Prevalence of Hyperhomocysteinemia in Cases of Deep Vein Thrombosis / G. T. Kamat, S. C. Metgut, V. M. Pattanshetti et al. // Indian J. Surg. 2010. Vol. 72(4).

P. 323326.

36. Vannucchi H. Hyperhomocysteinemia and cardiometabolic risk /H. Vannucchi, S. S. Melo // Arq Bras Endocrinol Metabol. 2009. Vol. 53(5). P. 540-549.

37. Loscalzo J. Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology / J. Loscalzo // J. Clin. Invest. 2009. Vol.119(11). P. 3203-3205.

38. Jensen R. T. Consequences of Long-Term Proton Pump Blockade:Insights from Studies of Patients with Gastrinomas / R. T. Jensen // Basic & Clinical Pharmacology & Toxicology. 2006. Vol. 98. P. 419.

39. Ruscin J. M. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor / J. M. Ruscin, R. L. Page, R. J. Valuck // The Annals of Pharmacotherapy. 2002. Vol. 36. P.

812816.

40. . . - : . . . . :

. 14.00.05 / . . . .-, 2004. 20 .

41. . . / . . , . . // . . 2010. . 3. 6. . 342353.

42. Oh R. C. Vitamin B12 Deficiency / R. C. Oh, D. L. Brown // American Family Physician. 2003. Vol.

67(5). P. 979986.

43. Ali T. Long-term Safety Concerns with Proton Pump Inhibitors / T. Ali, D. N. Roberts, W. M. Tierney // The American Journal of Medicine. 2009. Vol. 122. 10. P. 196203.

44. . . - / . . // . 2007. 3 (35). . 3237.




140 .


45. . . ( ) / . . , . . ³, .. // . 2011. , 2(36). . 2. . 151153.

46. Sumner . . Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery / . . Sumner, M. M. Chin, J. L.Abrahm et al. // Ann. Intern. Med. 1996. Vol. 124. P. 269476.

47. Redeen S. Homocysteine Levels in Chronic Gastritis and Other Conditions: Relations to Incident Cardiovascular Disease and Dementia / S. Redeen, A. Ryberg, F. Peterson et al. // Dig. Dis. Sci. 2010. Vol. 55. . 351358.

48. Abraham N. S. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents / N. S. Abraham, F. Chair, M. A. Hlatky et al. // Circulation. 2010. Vol. 122. P. 26192633.

49. Andres E. Vitamin B12 (cobalamin) deficiency in elderly patients / E. Andres, N. H. Loukili, E. Noel et al. // CMAJ. Vol. 171(3). P. 251259.

50. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II / R. Carmel // Am. J. Clin. Nutr. 2011. Vol. 94(1). P. 348358.

51. Nexo E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility / E. Nexo, E. Hoffmann-Lcke // Am. J. Clin. Nutr. 2011. Vol. 94(1). P. 359365.

52. Termanini B. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome / B. Termanini, F. Gibril, V. E. Sutliff et al. // Am. J. Med. 1998. Vol.

104(5). P. 422430.

53. Raghunath A. S. Review article: the long-term use of proton-pump inhibitors / A. S. Raghunath, C. OMorain, R. C. McLoughlin // Aliment. Pharmacol. Ther. 2005. Vol. 22 (Suppl.1). P. 5563.

54. Elzen W. P. J. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals / W. P. J. den Elzen, Y. Groeneveld, V. de Ruijter //Alimentary Pharmacology and Therapeutic. 2008. Vol.

27. P. 491497.

55. Deshmukh U. S. Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India / U. S. Deshmukh, C. V. Joglekar, H. G. Lubree et al. // Eur. J.

Clin. Nutr. 2010. Vol. 64(5). P. 495502.

56. Favrat B. Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial / B. Favrat, P. Vaucher, L. Herzig // BMC Fam Pract. 2011. Vol. 12, 2. P.

18.

57. Wakiewicz A. Dietary intake of vitamins B6, B12 and folate in relation to homocysteine serum concentration in the adult Polish population - WOBASZ Project / A. Wakiewicz, E. Sygnowska, G. Broda // Kardiol. Pol.

2010. Vol. 68(3). P. 275282.



Pages:     | 1 | 2 || 4 |
 >>  . C 01.02.00
:

35:341.233.1+351.82 . . Ͳֲ Բ . - . A study of vectors modernization of public financial control. The necessity of improving the existing legal mechanisms of state financial control in Ukraine. ...

: 004.056.3 .. , .. , ²ҲҲ ˲ ̲ Ҳ .., .., 2010 ᒺ . . Methods to ensure the fault-tolerance of nodes measure the speed of the object...

126 ISSN 0132-1471. . 2013. 91 539.3 .. , - . .. , - . .. , . . .. ˲ ̲ в ² ...

ISSN 1813-6796 ² 2012 6 , 675: 532.744 . . , . . , . ., . . òͲ Ҳ Բ ˲²Ͳ , . . , ...

URL: http://www.enemo.org.ua/ENEMO%20FINAL%20 STATEMENT%202006%20ukr.pdf. 8. . 2002 , 2002. URL: http://www.ucipr.kiev.ua/ ukrainian/adminresurs/001.html. 9. . 1999 -2004 // RU. 2003. 32 (327). URL: http: // www. polit. com.ua/?cgid=5&PHPSESSID=d1b71d947caaa03f2a29bcfa65015568&mpid=9®id=637&spoid=2& offs=70&poid=2&id=1866/. 10. ...

ISSN 2224-087X. 㳿. 2012. 2. . 27-32 Electronics and information technologies. 2012. Issue 2. P. 2732 в ί Ͳ 621.315.592 ֲ ϲ² ί ֲ . 1, . ij 1, . 1, . 1, . 1, . 1, . 1, . 2 . . , 107, 79017 , ...

658.3 .., ...,., , . IJͲ Ͳ - , . : - , , , , , . ...

005.2: 658 -Ͳ ϲ вҲ ί ò ϲȪ1 .., ..., , .., 㳿 , . : , , , , , . . .,...

ί Բ 543.422 Ѳ ̲ί ֲ̲ -ֲ в: ʲ 01.04.01 , - : . .-. . 2006 ̲ IJ 1 ̲Ͳ ֲͲ...

, 1526 , - . - ...




( )
.: (050)697-98-00, (067)176-69-25, (063)846-28-10
׸


 
<<     |    
2013 www.uk.x-pdf.ru -